Ocular Disease as a Comorbidity of Atopic Dermatitis

A variety of ocular disorders are commonly encountered in individuals affected by atopic dermatitis (AD). In addition to commonly observed ocular surface disease (OSD), other comorbid eye disorders seen inherently with AD include infections, keratoconjunctivitis, cataracts, and keratoconus. Some ocular diseases are recognized as potential adverse effects of therapies used to treat AD, especially topical and systemic corticosteroids, and biologic agents that inhibit interleukins (IL) 4 and/or 13. The latter includes dupilumab (IL-4/IL-13), tralokinumab (IL-13), and lebrikizumab (IL-13), all of which may be associated with OSD. This article serves to provide a thorough review of ocular diseases that are comorbidities of AD and/or occur in association with therapies used to treat AD.

Authors

Institutions

Publication Details

Journal
SKIN The Journal of Cutaneous Medicine
Published
2025-03-17
DOI
https://doi.org/10.25251/skin.9.2.2
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ocular Disease as a Comorbidity of Atopic Dermatitis

J.Q. Del Rosso, Kimberlee Tottori, David Tottori
SKIN The Journal of Cutaneous Medicine
Dermatology and Skin Diseases
article

Ocular Disease as a Comorbidity of Atopic Dermatitis

J.Q. Del Rosso, Kimberlee Tottori, David Tottori
article en

Abstract

A variety of ocular disorders are commonly encountered in individuals affected by atopic dermatitis (AD). In addition to commonly observed ocular surface disease (OSD), other comorbid eye disorders seen inherently with AD include infections, keratoconjunctivitis, cataracts, and keratoconus. Some ocular diseases are recognized as potential adverse effects of therapies used to treat AD, especially topical and systemic corticosteroids, and biologic agents that inhibit interleukins (IL) 4 and/or 13. The latter includes dupilumab (IL-4/IL-13), tralokinumab (IL-13), and lebrikizumab (IL-13), all of which may be associated with OSD. This article serves to provide a thorough review of ocular diseases that are comorbidities of AD and/or occur in association with therapies used to treat AD.

SKIN The Journal of Cutaneous MedicineVol. 9(2)
Touro University Nevada (US)
Openalex Percentile: Top 90%
Dermatology and Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.